Indices end at record high for 2nd day, Sensex gains 680 pts, tops 43K

All that happened in the markets today.

2:00 PM

BSE Midcap index underperforms Sensex

1:53 PM

European Union announces new tariffs as countermeasures against US exports

The European Union (EU) has put in place countermeasures against the US exports by slapping tariffs on American products worth $4 billion, the European Commission said in an official statement.

 

The measures will take effect on Tuesday, Xinhua news agency quoted European Commission Executive Vice-President Valdis Dombrovskis as saying at a press conference here on Monday. READ MORE

1:52 PM

MARKET CHECK

1:41 PM

Sept Quarter Result | Hindalco reports profit of Rs 198 crore vs Rs 78 crore YoY

1:34 PM

HDFC regains Rs 4 trillion m-cap; stock surges 6%, hits over 8-month high

Housing Development Finance Corporation (HDFC) regained the Rs 4 trillion-market capitalisation after the stock of the housing finance company rallied 6 per cent, hitting an over eight-month high of Rs 2,285 on the BSE on Tuesday. It was trading at its highest level since February 27, 2020. It had hit a 52-week high of Rs 2,500 on January 14, 2020. READ MORE 

1:26 PM

Covid-19 vaccine :: China vaccine trial halted in Brazil

The final-stage trial of a Chinese frontrunner vaccine candidate has been halted in Brazil due to a serious adverse event, the first time that any of the Asian nation’s rapidly developed Covid-19 shots have met with such a setback.

 

Testing of Sinovac Biotech Ltd.’s vaccine, called Coronavac, has been halted in Brazil after an event that occurred on Oct. 29, said the Brazil Health Agency on Tuesday, without giving any further detail on what happened. The study is interrupted in accordance with regulations while the agency analyses if the study should continue, it said. READ MORE

1:16 PM

Bihar Election Results :: Counting to continue till late evening, says Bihar chief electoral officer

1:13 PM

Sept Quarter Result | M&M reports profit of Rs 162 crore

>> Revenue at Rs 11,590 crore

>> EBITDA at Rs 2,057 crore

>> EBITDA margin at 17.7%

1:05 PM

BUZZING STOCK | IndusInd Bank climbs 10%

12:57 PM

Caution prevails over loan to parent despite Vedanta's strong Q2 show

The Street has become increasingly cautious about high promoter debt and Vedanta's inter-corporate lending. Despite being positive on Vedanta's near-term earnings outlook, analysts have lowered their target prices. Inter-corporate deposits (ICDs given to parent Vedanta Resources) and near-term debt repayments keep analysts at PhillipCapital cautious about the stock. They have discounted the oil and gas business cash-flow entirely on the risks of further ICD support, and have lowered their target price to Rs 126, from Rs 150. READ MORE

12:56 PM

ALERT :: Nifty tops 12,600 for the first time

12:45 PM

ALERT :: Sensex at day's high

12:35 PM

Ashok Leyland hits 52-wk high on demand recovery hope; stk up 73% in 3 mths

Shares of Ashok Leyland hit a 52-week high of Rs 89.45, surging 6 per cent on the BSE on Tuesday, on expectation that the domestic truck and light commercial vehicle (LCV) sector recovery may continue to gather pace over the second half (October-March) of the current fiscal. The stock of the commercial vehicle company has outperformed the market in the past three months by surging 73 per cent, as against 13 per cent rise in the S&P BSE Sensex. READ MORE

12:34 PM

BUZZING STOCK | Lemon Tree Hotels zooms 10%

12:26 PM

Voltas impresses street, scores over peers with strong show in Sept quarter

Voltas’ strength in the retail room AC segment continues to help in the current environment. Blue Star, though a formidable player, however, has a higher component of commercial sales (offices, projects and others). It is seeing recovery, however, and expects the momentum to continue in the upcoming festive season. It expects the market to reach 100 per cent of last year’s level by December. While Blue Star has maintained market share in room ACs at 12.7 per cent in Q2'FY21, analysts at Anand Rathi say the company’s ability to expand its market share is the key monitorable in FY21. READ MORE